Overview

Comparison of Pharmacokinetics of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing of 17-Beta-estradiol in Male-to-Female Transgender Patients

Status:
Not yet recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

Summary

This crossover study will investigate the pharmacokinetics of oral versus sublingual administration of 17-beta-estradiol in the trans-female population.

Phase:

Early Phase 1

Details

Lead Sponsor:

MaineHealth

Treatments:

Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Polyestradiol phosphate